Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of MenACWY-CRM vaccine exposure during pregnancy.
Becerra-Culqui TA, Sy LS, Ackerson BK, Chen LH, Fischetti CA, Solano Z, Schmidt JE, Malvisi L, Curina C, Pellegrini M, Tseng HF. Becerra-Culqui TA, et al. Among authors: pellegrini m. Vaccine. 2020 Mar 10;38(12):2683-2690. doi: 10.1016/j.vaccine.2020.02.008. Epub 2020 Feb 10. Vaccine. 2020. PMID: 32057568
Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months-55 years.
Yoo BW, Jung HL, Byeon YS, Han DK, Jeong NY, Curina C, Moraschini L, Kim SJ, Bhusal C, Pellegrini M, Miao Y. Yoo BW, et al. Among authors: pellegrini m. Hum Vaccin Immunother. 2020 Jun 2;16(6):1260-1267. doi: 10.1080/21645515.2019.1670125. Epub 2019 Oct 25. Hum Vaccin Immunother. 2020. PMID: 31634044 Free PMC article.
Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children.
Giuliani MM, Biolchi A, Keshavan P, Moriondo M, Tomei S, Santini L, Mori E, Brozzi A, Bodini M, Nieddu F, Ricci S, Mzolo T, Costantini M, Azzari C, Pellegrini M. Giuliani MM, et al. Among authors: pellegrini m. Hum Vaccin Immunother. 2021 May 4;17(5):1442-1449. doi: 10.1080/21645515.2020.1833578. Epub 2020 Dec 16. Hum Vaccin Immunother. 2021. PMID: 33325757 Free PMC article.
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Díez-Domingo J, Tinoco JC, Poder A, Dinleyici EC, Nell H, Salamanca de la Cueva I, Ince T, Moreira ED Jr, Ahmed K, Luz K, Kovshirina Y, Medina Pech CE, Akhund T, Romolini V, Costantini M, Mzolo T, Kunnel B, Lechevin I, Aggravi M, Tiberi P, Narendran K, García-Martínez JA, Basile V, Fragapane E, Lattanzi M, Pellegrini M. Díez-Domingo J, et al. Among authors: pellegrini m. Hum Vaccin Immunother. 2022 Dec 31;18(1):1981085. doi: 10.1080/21645515.2021.1981085. Epub 2021 Oct 6. Hum Vaccin Immunother. 2022. PMID: 34614379 Free PMC article. Clinical Trial.
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vandermeulen C, Leroux-Roels I, Vandeleur J, Staniscia T, Girard G, Ferguson M, Icardi G, Schwarz TF, Neville AM, Nolan T, Cinquetti S, Akhund T, Van Huyneghem S, Aggravi M, Kunnel B, de Wergifosse B, Domenico GFD, Costantini M, Vir Singh P, Fragapane E, Lattanzi M, Pellegrini M. Vandermeulen C, et al. Among authors: pellegrini m. Vaccine. 2021 Oct 29;39(45):6628-6636. doi: 10.1016/j.vaccine.2021.09.068. Epub 2021 Oct 9. Vaccine. 2021. PMID: 34635373 Free article. Clinical Trial.
1,664 results